Bufalin, a component of the Chinese medicine chan'su, induces apoptosis in various lines of human tumor cells, such as leukemia HL60 and U937 cells, by altering the expression of apoptosis-related genes, for example, bcl-2 and c-myc. In this study, we characterized a gene that is involved in bufalin-induced apoptosis by the dierential display (DD) technique. The partial nucleotide sequence of one of the dierentially expressed clones obtained after treatment with bufalin was identical to that of the human gene for Tiam1. When U937 cells were treated with 10 77 M bufalin, expression of both Tiam1 mRNA and the protein was induced 1 h after the start of the treatment. The increase of Tiam1 mRNA was transient but the level of Tiam1 protein continued to increase at least for 6 h. In addition, the activities of Rac1 and p21-activated kinase (PAK) were also stimulated by bufalin treatment. To evaluate the role of Tiam1 in the apoptotic process, we examined the eects of the expression of sense and antisense RNA for Tiam1 in U937 cells. Apoptosis was strongly induced by bufalin in cells that expressed sense RNA for Tiam1 as compared to apoptosis in control cells treated with bufalin only. Cells expressing antisense RNA for Tiam1 were signi®cantly more resistant than the control bufalin-treated cells to induction of DNA fragmentation in response to bufalin. Moreover, sense transformants had elevated activities of PAK and c-Jun NH 2 -terminal kinase (JNK). These results suggest that Tiam1 might play a critical role in bufalin-induced apoptosis through the activation of Rac1, PAK, and JNK pathway.
Introduction
Apoptosis, also known as programmed cell death, is distinct from necrosis because it is an active process that leads to cell death (Kerr et al., 1972) . Apoptosis is thought to play a key role in embryogenesis (Pierce et al., 1989) , carcinogenesis (Vaux et al., 1988) , and the killing of virally infected cells (Laurent-Crawford et al., 1991) . Although apoptosis is initiated by many physiological and pathological stimuli, all apoptotic cells undergo a similar sequence of morphological and biochemical events (Martin et al., 1994) , which include condensation of the chromatin in the nucleus; fragmentation of DNA into fragments with lengths that are multiples of approximately 180 bp, as a result of speci®c cleavage between nucleosomes by an endogenous endonuclease; and a relatively high degree of preservation of the plasma membrane and cytoplasmic organelles.
Apoptosis-inducing agents speci®c for tumor cells might be expected to be ideal antitumor drugs since apoptotic cell death does not induce an in¯ammatory response. Chemotherapeutic agents, such as cisplatin (Kaufmann, 1989; Barry et al., 1990) and taxol (Bhalla et al., 1993) , and inhibitors of topoisomerases I and II, such as camptothecin and etoposide (Kaufmann, 1989; Walker et al., 1991; Onishi et al., 1993) , induce apoptosis. We have shown that bufalin, a component of the traditional Chinese medicine chan'su, acts as a potent dierentiation-and apoptosis-inducing agent in various lines of tumor cells (Zhang et al., 1991; Jing et al., 1994; Masuda et al., 1995) .
A number of regulators of cell functions, such as p53, c-myc, and members of the activating protein-1 (AP-1) family are associated with apoptosis. Therefore, it seems likely that they might be involved in early regulatory events in the genetic program that leads to cell death (Colotta et al., 1992) . We showed previously that the levels of expression of certain apoptosis-related genes, namely, c-myc and bcl-2, decrease upon treatment of cells with bufalin (Masuda et al., 1995) .
In the present study, we searched for other apoptosis-related genes whose expression is induced by bufalin in human leukemia cells using the dierential display (DD) technique. The DD technique is particularly suitable for such analysis and has recently been successfully applied to various systems (Liang and Pardee, 1992) . Using this method, we identi®ed a gene that was homologous to a human gene for Tiam1. Tiam1 was originally identi®ed in Tlymphoma cells as the product of an invasion-and metastasis-inducing gene (Habets et al., 1994) . The predicted Tiam1 protein contains a Dbl homology (DH) domain (Hart et al., 1994) and two pleckstrin homology (PH) domains (Harlan et al., 1994; Touhara et al., 1995) . The DH domain is present in GDPdissociation stimulator (GDS) proteins for Rho-like GTPases, such as Rac and Cdc42, and is considered to be a catalytic domain (Hart et al., 1994) . Tiam1 is one of GDS proteins for Rac, such as Vav (Crespo et al., 1996) and PIX , and it speci®cally activates Rac in vitro as well as in vivo (Michiels et al., 1995) . A novel family of recently identi®ed serine/ threonine kinases, designated PAKs, consists of 60 ± 70 kDa proteins whose carboxy-terminal catalytic domains are 60 ± 70% homologous to that of protein kinase Ste20 of Saccharomyces cerevisiae and whose amino-terminal segments each contain a Rac1/Cdc42-binding domain (Manser et al., 1994) . The PAKs are activated directly upon interaction with the GTPbound form of Rac1/Cdc42Hs in vitro. The PH domain, present in many signaling proteins, has been reported to be involved in protein-protein and proteinphospholipid interactions and might play a role in translocation of these proteins to membranes (Harlan et al., 1994; Touhara et al., 1995) .
We demonstrate here that expression of Tiam1 is induced by bufalin and that Tiam1 stimulates the JNK pathway through activation of Rac1 and PAK. Our results suggest that Tiam1 might play an important role in bufalin-induced apoptosis.
Results

Analysis of gene expression during bufalin-induced apoptosis
To evaluate the genes involved in bufalin-induced apoptosis in human leukemia cells, such as HL60 and U937 cells, we performed DD ± polymerase chain reaction (PCR) using RNA prepared from these leukemia cells after treatment with 10 78 M bufalin. A total of 40 polymerase chain reactions was performed with four anchor primers and ten dierent arbitrary primers for each sample of RNA and the products of PCR were separated on polyacrylamide gels. Figure 1a shows the results of DD ± PCR for HL60 cells that had been treated with 10 78 M bufalin for 3 h with T 12 MA as anchor primer and the AP1-4 set of arbitrary primers. Expression of several mRNAs was either induced or suppressed by bufalin (only part of the autoradiogram is shown in Figure 1a ). Among the cDNAs produced by PCR, one clone, designated BA1-2I, that was ampli®ed with the T 12 MA anchor primer and the AP1 primer set, corresponded to a gene that was strongly induced by bufalin (Figure 1a, asterisk) . Figure 1b shows the results of DD ± PCR, performed under the same conditions, for U937 cells treated with 10 78 M bufalin for various times. In this case, only the band designated BA1-2I is shown. The BA1-2I band obtained from U937 cells also increased signi®cantly in intensity within 1 ± 6 h after the start of bufalin treatment and the results were well correlated with the results obtained with HL60 cells. The BA1-2I band was cut out from the gel and the cDNA was reampli®ed.
Identi®cation of clone BA1-2I
The BA1-2I clone was characterized in further detail. The partial nucleotide sequence, determined by the dideoxy chain-termination method, was identical to that of the cDNA for Tiam1 from human brain (Figure 2 ). Since an increase in the level of expression of mRNA for Tiam1 was detected in both HL60 and U937 cells that had been treated with bufalin, we investigated the eect of bufalin on induction of expression of Tiam1 by Northern blotting analysis. The level of expression of mRNA for Tiam1 in U937 cells started to increase 0.5 h after the start of treatment with bufalin, reaching a maximum at 1 h, and then it decreased (Figure 3a) . We also examined the eect of bufalin on the expression of the Tiam1 protein in U937 cells. Figure 3b shows the results of Western blotting analysis of expression of the Tiam1 protein. The level of Tiam1 protein was also elevated 1 h after the start of treatment with bufalin.
Eects of bufalin on stimulation of the activities of Rac1 and PAK
Since Tiam1 is known to be an activator of Rac1, we examined whether the increase in expression of Tiam1 caused by bufalin could aect Rac1 activity in U937 . These results suggest that bufalin increases the level of the active form of Rac1 by inducing expression of Tiam1. We next investigated whether bufalin might also stimulate the activity of PAK, which acts downstream of Rac. Figure 4b shows that the phosphorylation of myelin basic protein (MBP) by PAK was stimulated to a signi®cant extent 1 h after the start of treatment with bufalin. This activation of PAK continued for at least 6 h. This result suggests that bufalin stimulated PAK activity through the activation of Rac1.
Eects of the expression of sense and antisense RNAs for Tiam1 on the JNK signal transduction pathway
To con®rm that changes in the level of Tiam1 mRNA were important in the apoptotic process induced by bufalin, we transfected U937 cells with Tiam1 sense and antisense expression vectors in which transcription was driven by the dexamethasone-inducible LTR promoter of mouse mammary tumor virus (Lee et al., 1981) . Four stable clones expressing sense and antisense Tiam1, respectively, were cloned by limiting dilution and two each of the G418-resistant clones that expressed sense and antisense Tiam1, respectively, were subjected to assays of Tiam1 protein and of activities of PAK and JNK ( Figure 5 ). Figure 5a shows the eects of treatment with dexamethasone and bufalin on the expression of Tiam1 protein in the various transformants. Tiam1 protein was not detected without bufalin treatment (lanes 1 and 2). Tiam1 protein was expressed in the cells with the empty vector upon treatment with dexamethasone that was followed by treatment with bufalin for 24 h (lane 3). The treatment with dexamethasone and bufalin caused a decrease in the amount of Tiam1 expressed in the Tiam1 antisense transformant, but caused a signi®cant increase in the Tiam1 sense transformant (lane 5), as compared with that in cells with the empty vector. Figure 5b shows the eects of treatment with dexamethasone and bufalin on levels of GDS activity in the respective transformants. GDS activity increased considerably in the Tiam1 sense transformant upon treatment with dexamethasone as compared to wild-type cells or transformants with an empty vector. However, dexamethasone had no eect on the GDS activity in the antisense transformant as compared with the cells with the empty vector. When transformants were treated with bufalin 24 h after the start of treatment with dexamethasone, the extent of induction of GDS activity in the antisense transformant was smaller than that in the wild-type cells, in cells transformed with the empty vector, and in the sense transformant, suggesting that bufalin-induced GDS activity was inhibited by the expression of antisense RNA for Tiam1. Identical results were obtained with the other sense and antisense transformants (results not shown). We also examined the eect of bufalin on the PAK activity in these transformants under the same experimental conditions as those used to obtain the results shown in Figure 5b . As shown in Figure 5c , PAK activity in the Tiam1 sense transformant was greatly increased (lane 3), as compared to that in the empty-vector transformant (lane 2). By contrast, in the antisense transformant, no signi®cant activation of PAK by bufalin was detected (lane 4). Since Rac and Cdc42 are able to stimulate JNK activity (Coso et al., 1995) , we investigated whether treatment with bufalin might aect JNK activity in the Tiam1 sense and antisense transformants. In agreement with a previous report (Watabe et al., 1998) , JNK in the empty-vector transformant was activated by the treatment with bufalin (lane 2 in Figure 5d ). Moreover, bufalin caused much more marked activation of JNK in the Tiam1 sense transformant (lane 3) than in the empty-vector transformant (lane 2), whereas no activation of JNK was observed in the antisense transformant (lane 4). Thus, activation of JNK by bufalin was closely correlated with activation of PAK, as shown in Figure 5b . Essentially the same results were obtained when we examined the eects of dexamethasone and bufalin on the activities of PAK and JNK in the other sense and antisense transformants (results not shown).
Eects of the expression of sense and antisense RNAs for Tiam1 on bufalin-induced apoptosis
To examine whether Tiam1 might participate in the bufalin-induced fragmentation of DNA, we analysed nucleosomal DNA extracted from bufalin-treated transformants by agarose gel electrophoresis and quanti®ed the level of fragmented DNA using DAPI, as described in`Materials and methods'. As shown in Figure 5a , bufalin induced DNA fragmentation in empty-vector transformants, as well as in wild-type U937 cells (lanes 2 and 3). Moreover, the extent of DNA fragmentation in the Tiam1 sense transformant was markedly higher than that in the empty-vector transformant. By contrast, practically no fragmentation of DNA was induced by bufalin in the Tiam1 antisense transformant (lane 5). As shown in Figure  6b , the extent of DNA fragmentation in wild-type U937 cells (wt +) and in the empty-vector transformant (neo+) was greater than that in untreated control cells (wt 7). Moreover, the fragmentation of DNA induced by bufalin in the Tiam1 sense transformant (sense+) was much greater than that in wild-type U937 cells (wt +) or in the empty-vector transformant (neo+) treated with bufalin. By contrast, bufalin-induced fragmentation of DNA was markedly inhibited in the Tiam1 antisense transformant (antisense+) and the level was the same as in the untreated wild-type U937 cells (wt 7). These results, shown in Figure 6b , are well correlated with those in Figure 6a . Thus, taken together, these results suggest that expression of the gene for Tiam1 might be involved in the apoptotic process induced by bufalin in U937 cells. 
Discussion
In this study, we investigated genes involved in bufalininduced apoptosis by the DD ± PCR method and we found that expression of a gene for Tiam1 was induced by bufalin. The increased levels of expression of Tiam1 mRNA and protein were con®rmed by Northern and Western blotting analyses. As we demonstrated in the present study (Figure 6 ), expression of sense and antisense RNAs for Tiam1 in U937 cells resulted in increased and decreased DNA fragmentation, respectively, in response to bufalin, as compared to that observed in the empty-vector transformant, as well as in wild-type U937 cells. Furthermore, we examined whether cyclohexamide, an inhibitor of protein synthesis, might inhibit the DNA fragmentation caused by bufalin. As shown in Figure 7 , pretreatment with 1 mg/ml cyclohexamide for 1 h signi®cantly inhibited DNA fragmentation in U937 cells that was caused by incubation with 10 76 M bufalin for 5 h. We also demonstrated that bufalin activated Rac1, PAK, and JNK, which act downstream of Tiam1. It has previously been demonstrated that Tiam1 activates Rho-like GTPases, such as Rac1 and Cdc42 (Michiels et al., 1995) , and that activated Rac1 and Cdc42 can speci®cally activate PAK (Manser et al., 1994; Knaus et al., 1995) . Vojtek and Cooper (1995) showed that Rac activates the MEKK/SEK/JNK cascade through PAK. Recently, PAK was reported to be able to act upstream of Rac in the induction of morphological changes in PC12 cells (Obermeier et al., 1998) . We can conclude from our present results that bufalin causes an increase in expression of Tiam1, which probably leads to the successive activation of Rac1, PAK, and JNK, and results ®nally in the induction of apoptosis. It was, however, unclear whether a signal was transmitted through Rac1 to PAK and PAK to JNK, and the possibility that JNK might have been activated through another pathway that did not involve Rac1 was not excluded.
It has been reported that activation of the JNK pathway contributes to the induction of apoptosis. JNK signaling is required for ceramide-mediated apoptosis in U937 cells (Sawai et al., 1995; Verheij et al., 1996) . JNK also regulates apoptosis of human 
of results from three independent experiments
Tiam1 regulates bufalin-induced apoptosis N Kawazoe et al small-cell lung cancer cells that is induced by ultraviolet (UV) irradiation (Butter®eld et al., 1997) and withdrawal of nerve growth factor (NGF) from rat PC12 pheochromocytoma cells results in increased activities of JNK and p38 with subsequent apoptotic cell death (Xia et al., 1995) . In a recent report, we demonstrated that JNK activity is increased when U937 cells are treated with bufalin (Watabe et al., 1998) . Another member of the mitogen-activated protein kinase (MAPK) family, p38, was ®rst identi®ed as a protein that is phosphorylated at a tyrosine residue upon treatment of murine pre-B cells with lipopolysaccharide (LPS) (Han et al., 1993) . Further studies have shown that p38 is activated in response to hyperosmolarity and mediators of inflammation, such as interleukin-1 (IL-1) and tumor necrosis factor a (TNF-a) (Han et al., 1994; Raingeaud et al., 1995) . Both JNK and p38 are activated during apoptosis that is induced by various environmental stresses, such as heat shock, osmotic stress and UV light (Xia et al., 1995; Raingeaud et al., 1995; Galcheva-Gargova et al., 1994; Kyriakis and Avruch, 1996) . The withdrawal of NGF from cultures of PC12 cells leads to activation of JNK and p38 and inhibition of ERK (Xia et al., 1995) . In contrast to these results, JNK appears not to be involved in apoptosis that is induced in human breast carcinoma MCF7 cells by TNF-a (Liu et al., 1996) . In Fas-induced apoptosis, JNK and p38 are essential for the morphological changes associated with apoptosis but are not necessary for DNA fragmentation (Toyoshima et al., 1997) . Furthermore, Roulston et al. (1998) suggested that JNK and p38 might play a protective role during apoptosis by demonstrating that transient transfection of NIH-3T3 cells with plasmids that encoded dominant negative mutants of MKK4 and MKK6 or the addition of an inhibitor of p38, SB203580, to L929-cyt16 cells sensitized the respective cells to TNF-ainduced apoptosis. We observed previously that bufalin induced the sustained activation of ERK (Watabe et al., 1996) and the transient activation of JNK (Watabe et al., 1998) , but only slight activation of p38, prior to the induction of apoptosis (results not shown). We also observed that expression of a constitutively active mutant form of MEK1 to U937 cells resulted in the transcriptional activation of AP-1 and subsequent apoptosis, although the apoptosis-inducing activity of constitutively active MEK1 was much weaker than that observed upon addition of bufalin (Watabe et al., 1998) . These observations suggest the possibility that activation of only JNK or ERK might be insucient to induce apoptosis and that another signal, for example from Tiam1, might enhance signals for induction of apoptosis.
The Na + ,K + -ATPase seems likely to be an early target of bufalin because the plasma membrane is impermeable to bufalin (Numazawa et al., 1994) , and the activity of the Na + ,K + -ATPase in various lines of tumor cells is strongly inhibited by bufalin (Zhang et al., 1991) . Although the detailed mechanism is unknown, a signal might be transmitted from Na + ,K + -ATPase to Ras. With respect to the mechanism of stimulation of the expression of Tiam1 by bufalin, the following possibilities can be considered. One possibility is that both the Ras-Raf1-MEK-ERK and Rac-MEKK-SEK-JNK signaling pathways are activated almost simultaneously by bufalin. Signal transduction pathways from Ras to MEK kinase (MEKK) (Minden et al., 1994) and from Ras to Rac (Ridley et al., 1992) , albeit indirect pathways, have been reported. In addition, constitutively active MEK1 stimulates JNK in U937 cells (Franklin and Kraft, 1995) . One or some of the transcription factors that are activated upon the activation of ERK and JNK by bufalin might induce an increase in the level of expression of Tiam1; the activated Tiam1 might then enhance signals via Rac to JNK with ecient induction of apoptosis. This possibility is, however, unlikely since we demonstrated previously that activation of JNK (Watabe et al., 1998) and ERK (Watabe et al., 1996) in U937 cells by bufalin required 3 and 6 h, respectively, which are by far longer than the period, 1 h, required for the expression of Tiam1 protein, as demonstrated in the present study. To exclude this possibility more de®nitively, we treated U937 cells, after starvation for 24 h, with 10 77 M bufalin for various times in the presence of 25 mM PD98059, which is an inhibitor of MEK1, and then we analysed the expression of Tiam1 by Western blotting. The induction of Tiam1 by bufalin was unaected by PD98059 (results not shown). Another possibility is that expression of Tiam1 might be increased by some unknown signaling pathway(s) other than the Ras-Raf1-MEK-ERK and Rac-MEKK-SEK-JNK pathways. The strongly expressed Tiam1 might stimulate reactions on the Rac-MEKK-SEK-JNK pathway, and the enhanced signal, together with the Ras-Raf1-MEK-ERK pathway, might lead to apoptosis. Further studies are needed to examine these possibilities.
In addition to playing an important role in the induction of apoptosis, Rac/Cdc42 proteins have recently been shown to be important in cellular responses, in particular in the regulation of cytoskeletal organization in various lines of mammalian cells (Kozma et al., 1995; Nobes and Hall, 1995) . In ®broblasts, activation of Rac and Cdc42 results in the formation of focal complexes and lamellipodia or ®lopodia, respectively (Nobes and Hall, 1995) . In con¯uent serum-starved Swiss 3T3 cells, microinjection of constitutively active Rac1 (V12rac1) causes the accumulation of actin ®laments on the plasma membrane and induces membrane ruing (Ridley et al., 1992) . Overexpression of Tiam1 in ®broblasts also induces the formation of rues (Michiels et al., 1997) . Although Rac1 activates the JNK pathway, it is possible that another function of Rac1, such as regulation of cytoskeletal organization or the induction of membrane ruing, might be associated with bufalin-induced apoptosis. Further work is needed to examine whether the induction of membrane ruing is required for bufalin-induced apoptosis.
Materials and methods
Materials, cells, and cell culture
Bufalin, 4', 6-diamidino-2-phenylindole (DAPI) and MBP were purchased from Sigma Chemical Co. (St. Louis, MO, USA). G418 (geneticin disulfate) was obtained from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Rabbit polyclonal antibodies against Tiam (C-16), rabbit polyclonal antibodies against aPAK (C-19), and rabbit 35 S]GTPgS (1000 ± 1500 Ci/mmol) was purchased from DuPont NEN Research Products (Boston, MA, USA). Human leukemia HL60 cells and U937 cells were obtained from the Japanese Cancer Resource Bank (Osaka, Japan). These cells were cultured in RPMI-1640 medium supplemented with 10% fetal calf serum at 378C in an atmosphere of 5% CO 2 in air. The cells (1610 7 cells) were deprived of serum for 24 h prior to the addition of bufalin. The cells were treated with 10 77 M bufalin, except when they were to be used for DD, in serum-free RPMI-1640 for the times indicated. For DD, the leukemia cells were treated with 10 78 M bufalin.
Isolation of RNA and dierential display (DD)
Total RNA was prepared by the acid guanidinium thiocyanate-phenol-chloroform method (Chomczynski and Sacchi, 1987) . Dierential display using the polymerase chain reaction (DD ± PCR) was performed with puri®ed samples of total RNA and an RNAmap kit (GenHunter Co., Brookline, MA, USA). In brief, cDNAs were reverse transcribed from total RNA (0.2 mg) using four dierent anchor primers that contained oligodT. The cDNAs were then ampli®ed using sets of anchor and arbitrary primers in the presence of [ 35 S]dATP. The fragments after PCR, labeled with 35 S, were resolved on a 6% (w/v) polyacrylamide denaturing gel. Un®xed gels were dried and exposed to X-ray ®lm for visualization of products of PCR.
Dierentially expressed bands were cut from the gel and rehydrated in 100 ml H 2 O by boiling for 15 min. The released DNA was precipitated with ethanol and reampli®ed by PCR with the original set of primers. The ampli®ed DNA was visualized on a 1% (w/v) agarose gel. Successfully reampli®ed cDNAs were cloned into the pMOSBlue vector using the pMOSBlueT-vector kit (Amersham). DNA inserts were sequenced with a BcaBEST dideoxy sequencing kit (Takara Biochemicals Inc., Kyoto, Japan).
Construction of Tiam1 expression plasmids
Two oligonucleotides, 5'-TCCCGGGCTAGCCATAAAA-CCATGGGAAACG-3' and 5'-TAAGCTTGCTAGCT-GACGCAGTCAGATCTCAG-3', designated Tiam1F and Tiam1R, respectively, were used as primers for PCR for ampli®cation of the gene for Tiam1. Long and accurate-PCR (LA ± PCR) was performed in the presence of 2.5 U of Takara LA Taq polymerase (Takara Biochemicals Inc.) for 30 cycles with a step program (988C, 20 s; 688C, 10 min) that was followed by a ®nal extension at 728C for 10 min. Products of PCR were subjected to electrophoresis in a 1% (w/v) agarose gel and then stained with ethidium bromide.
Tiam1 cDNA was generated from HL60 mRNA by LA ± PCR with two oligonucleotides as primers, as described above for ampli®cation. The 5 kb NheI fragment that encoded the entire human gene for Tiam1 and the antisense fragment were cloned into the NheI site of the pMAM-neo vector.
Northern blotting analysis
Total RNA was prepared by the method of Chomczynski and Sacchi (1987) , and aliquots of 15 mg of RNA were subjected to electrophoresis on 1% denaturing agarose gels that contained formaldehyde and transferred onto Hybond-N membranes (Amersham, UK). Northern blotting analysis was performed as described previously (Maniatis et al., 1982) .
Immunoblotting
Cells were collected by centrifugation and washed twice with phosphate-buered saline (PBS). The washed cells were lysed with 0.3 ml of lysis buer, which consisted of 10 mM Tris-HCl (pH 7.4), 5 mM EDTA, 5 mM EGTA, 0.15 M NaCl, 2 mg/ml aprotinin, 2 mg/ml leupeptin, 2 mg/ml pepstatin A, 2 mg/ml antipain, 0.5 mM phenylmethylsulfonyl¯uoride (PMSF), 50 mM NaF, 2 mM sodium orthovanadate, 10 mM sodium pyrophosphate, and 1% (w/v) Triton X-100. Each cell lysate was centrifuged at 15 000 g for 20 min and the supernatant was used for immunoblotting and measurements of protein kinase activities.
Cell lysates containing 20 mg of total protein were analysed by Western blotting. After SDS ± polyacrylamide gel electrophoresis, bands of protein were transferred to a polyvinylidene di¯uoride membrane and immunoblotted with appropriate rabbit polyclonal antibodies. Immunocomplexes were visualized with the ECL detection system (DuPont NEN Research Products).
Assays of the activity of Tiam1
Full-length cDNA for human Rac1 was generated by RT ± PCR with total RNA extracted from HL60 cells that had been treated with dibutyryl cyclic AMP (Didsbury and Snyderman, 1987) . For PCR, we used the forward primer 5'-AGGATCCACATGCAGGCCATCAAGTGTG-3' and the reverse primer 5'-AGGATCCTTACAACAGCAGG-CATTTTC-3'. PCR was performed in the presence of 2.5 U of Takara Ex Taq polymerase (Takara Biochemicals Inc.) for 30 cycles with a step program (948C, 30 s; 528C, 30 s; 728C, 2 min), that was followed by a 7-min ®nal extension at 728C. The product of PCR was cloned into the BamHI site of the pGEX-3X vector. Expression of glutathione-S-transferase-Rac1 (GST-Rac1) fusion protein was induced in E. coli BL21 cells by treatment with 1 mM isopropyl b-D-thiogalactopyranoside (IPTG) for 5 h. Bacteria were sonicated in PBS that contained 1% (w/v) Triton X-100, 1% (w/v) Tween 20, and 0.1% (w/v) Nlauroylsarcosine and centrifuged at 15 000 g for 10 min at 48C. The fusion protein was puri®ed by passage of the supernatant through column of Glutathione-Sepharose 4B.
GST-Rac1 (2 pmol) was incubated with 1 mM [ 35 S]GTPgS (6 ± 8610 3 c.p.m./pmol) in the presence of a cell lysate (40 mg of protein) in a reaction mixture (50 ml) that contained 20 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , 2.5 mM EDTA, 1 mM dithiothreitol (DTT), and 1 mM L-a-dimyristoylphosphatidylcholine. After incubation for 30 min at 258C, the reaction was stopped by the addition of about 1 ml of icecold 20 mM Tris-HCl (pH 7.5) that contained 25 mM MgCl 2 and 100 mM NaCl. The diluted mixture was ®ltered through a nitrocellulose ®lter and the ®lter was washed four times with the same solution. The ®lter was dissolved in 5 ml of scintillation cocktail and then radioactivity was quantitated. Tiam1 activity, as assayed by this method, was expressed as the increase in radioactivity trapped on a ®lter in the presence of Tiam1 as compared to that trapped in the absence of Tiam1.
Immunoprecipitation and assays in vitro of the kinase activities of PAK and p38
The kinase activities of PAK and p38 in cell lysates were measured. After stimulation of cells with bufalin, cell lysates (0.5 mg of protein) were cleared by mixing with Tiam1 regulates bufalin-induced apoptosis N Kawazoe et al 15 ml of a 50% (v/v) suspension of Protein G-Sepharose beads. Immunoprecipitation reactions were incubated for 1 h at 48C with 1.5 mg of each appropriate antibody plus 30 ml of a 50% (v/v) suspension of Protein G-Sepharose beads. The beads were then washed twice with the washing buer [20 mM HEPES (pH 7.4), 0.5 M NaCl, 2.5 mM MgCl 2 , 0.1% (w/v) Triton X-100, 0.005% (w/v) SDS, 2 mg/ml leupeptin, 0.5 mM sodium orthovanadate and 0.5 mM PMSF] and once with the appropriate buer [for assays of PAK, the buer contained 50 mM HEPES (pH 7.6), 10 mM MgCl 2 , 1 mM MnCl 2 , 1 mM DTT, 100 mM NaCl, 0.1 mM sodium orthovanadate, 20 mM bglycerophosphate and 20 mM p-nitrophenylphosphate; for assays of p38, the buer contained 25 mM HEPES (pH 7.6), 20 mM MgCl 2 , 1 mM DTT, 0.1 mM sodium orthovanadate, 20 mM b-glycerophosphate and 20 mM pnitrophenylphosphate]. Assays were conducted in the appropriate buer with 0.1 mM [g-32 P]ATP (0.1 mCi) and 20 mg MBP as substrate. Each reaction was terminated by addition of Laemmli's loading buer (Laemmli, 1970) . Proteins were subjected to electrophoresis in 13.5% (w/v) polyacrylamide non-denaturing gels. The gels were dried and then phosphorylated proteins were visualized by autoradiography.
Assay of JNK activity
A fusion vector for expression of GST-c-Jun (1 ± 79) was constructed by inserting a fragment of the c-jun gene (corresponding to codons 1 ± 79) into the pGEX-3X vector. The fusion protein was expressed in E. coli BL21 cells and puri®ed with Glutathione-Sepharose 4B.
JNK activity was determined by incubation of the whole cell lysates (0.5 mg of protein) with 10 mg of GST-c-Jun (1 ± 79) conjugated to Glutathione-Sepharose 4B beads (prepared according to the manufacturer's instructions; Pharmacia) for 1 h at 48C. The beads were washed three times with HEPES binding buer [20 mM HEPES (pH 8.0), 2.5 mM MgCl 2 , 0.1 mM EDTA, 50 mM NaCl, 0.05% (w/v) Triton X-100]. The ®nal wash was performed with kinase buer [20 mM HEPES (pH 8.0), 20 mM MgCl 2 , 20 mM b-glycerophosphate, 0.1 mM sodium orthovanadate, 2 mM DTT]. The kinase reaction was initiated by resuspending the pelleted beads in 30 ml of kinase buer plus [g-32 P]ATP (20 mM; 0.2 mCi/ reaction) and incubating the mixture for 10 min at 308C. The reactions were terminated by addition of 1 ml of ice-cold HEPES binding buer, and then the beads were pelleted, resuspended in Laemmli's loading buer, and boiled 5 min. Proteins were resolved by electrophoresis on SDS ± polyacrylamide (12% w/v) gels, with subsequent autoradiography.
Transfection of U937 cells
Transfections were performed by electroporation (Gene Pulsor; Bio-Rad, Hercules, CA, USA) as described previously (Noguchi et al., 1995) . The electric pulse was delivered to 0.4 ml of a suspension of U937 cells (4610 6 cells) that contained 10 mg of plasmid DNA. Then cells (1610 4 cells per well) were plated in 96-well microplates and cultured in RPMI-1640 medium. After culture for 24 h, G418 was added at a ®nal concentration of 0.4 mg/ ml, and subclones were isolated 2 ± 3 weeks later.
Detection of DNA fragmentation DNA was prepared for gel electrophoresis as described previously (Martin et al., 1990) . Electrophoresis was performed in a 1% (w/v) agarose gel in 40 mM Trisacetate buer (pH 7.4) at 50 V for 1 h. The fragmented DNA was visualized by staining with ethidium bromide after electrophoresis.
Quanti®cation of DNA fragmentation
DNA fragmentation was quantitated as reported elsewhere (Wyllie, 1980) . In brief, cells, harvested by centrifugation, were lysed in a solution of 5 mM Tris-HCl (pH 7.4) and 1 mM EDTA that contained 0.5% (w/v) Triton X-100 for 20 min on ice. The lysate and the supernatant after centrifugation at 27 000 g for 20 min were sonicated for 40 s, and the level of DNA in each was measured by ā uorometric method with the¯uorescent reagent DAPI. The amount of DNA fragmented was calculated as the ratio of the amount of DNA in the supernatant to that in the lysate, multiplied by 100 to give a percentage.
